Tc Biopharm (Holdings) PLC (TCBWF) — 8-K Filings

8-K Filings (12)

• TC BioPharm Board Changes Announced — Jun 28, 2024 Risk: medium
  TC BioPharm (Holdings) plc announced on June 26, 2024, a change in its board of directors. Specifically, the company reported the departure of certain officers
• TC Biopharm Faces Delisting Concerns — May 29, 2024 Risk: high
  TC Biopharm (Holdings) plc filed an 8-K on May 29, 2024, reporting a notice of delisting or failure to satisfy continued listing rules as of May 24, 2024. The c
• TC Biopharm Files 8-K for Other Events — May 20, 2024 Risk: medium
  TC Biopharm (Holdings) plc filed an 8-K on May 20, 2024, reporting "Other Events." The filing does not contain specific financial figures or detailed event desc
• TC BioPharm Files 8-K: Material Agreement & Equity Sales — May 8, 2024 Risk: medium
  On May 6, 2024, TC BioPharm (Holdings) plc entered into a material definitive agreement. The company also reported on unregistered sales of equity securities an
• TC Biopharm Files 8-K for Financials — May 6, 2024 Risk: low
  TC Biopharm (Holdings) plc filed an 8-K on May 6, 2024, reporting events as of May 1, 2024. The filing primarily concerns financial statements and exhibits, wit
• TC Biopharm Files 8-K, Reports Corporate Changes — Apr 4, 2024 Risk: medium
  TC Biopharm (Holdings) plc filed an 8-K on April 4, 2024, reporting events as of April 1, 2024. The filing indicates changes in the company's structure and pote
• TC Biopharm (Holdings) plc Files 8-K on Shareholder Vote — Mar 19, 2024 Risk: medium
  TC Biopharm (Holdings) plc filed an 8-K on March 19, 2024, reporting that a matter was submitted to a vote of security holders on March 14, 2024. The filing doe
• TC Biopharm Raises $500K in Private Placement — Mar 18, 2024 Risk: medium
  On March 12, 2024, TC Biopharm (Holdings) plc announced the closing of a private placement of 1,000,000 ordinary shares at a price of $0.50 per share, raising g
• TC Biopharm Reports Equity Sales & Director Changes — Mar 12, 2024 Risk: medium
  TC Biopharm (Holdings) plc filed an 8-K on March 12, 2024, reporting on unregistered sales of equity securities and changes in directors and officers. The filin
• TC Biopharm Reports Director Changes and Officer Appointments — Mar 6, 2024 Risk: medium
  TC Biopharm (Holdings) plc filed an 8-K on March 6, 2024, reporting events as of February 29, 2024. The filing primarily concerns the departure of directors or
• TC BioPharm Files 8-K on Feb 14 for Feb 13 Event — Feb 14, 2024 Risk: medium
  TC BioPharm (Holdings) PLC filed an 8-K with the SEC on February 14, 2024, reporting an event that occurred on February 13, 2024. The filing indicates disclosur
• TC BioPharm Faces Nasdaq Delisting Warning Over Bid Price Rule — Jan 4, 2024
  TC BioPharm (Holdings) plc announced on January 4, 2024, that it received a delisting notice from Nasdaq on December 28, 2023, because its American Depositary S

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX